Rare diseases
Investigational molecules
Locations
353 conditions with trials, the busiest first
844 trials across Europe, recruiting first
Study on Long-Term Spesolimab Treatment for Patients with Generalized Pustular Psoriasis from Previous Trials
BelgiumStudy on the Safety and Effectiveness of Pembrolizumab and Drug Combination for Patients with Stage III Melanoma Eligible for Neoadjuvant Therapy
FranceStudy on the Safety and Effectiveness of Pembrolizumab and Tretinoin in Patients with PD-1 Refractory Melanoma
FranceStudy of E7386 and Pembrolizumab for Patients with Previously Treated Colorectal Cancer, Melanoma, or Hepatocellular Carcinoma
SpainStudy of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors
NorwayStudy on Amlitelimab for Adults with Moderate to Severe Hidradenitis Suppurativa
FranceStudy of Afamelanotide for Patients with Erythropoietic Protoporphyria (EPP)
BelgiumStudy on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors
AustriaStudy on MK-6194 for Adults with Systemic Lupus Erythematosus
FranceLong-term Safety Study of KVD900 for Treating Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema Type I or II
AustriaStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy
BelgiumStudy on the Effectiveness and Safety of allo-APZ2-CVU for Healing Chronic Venous Ulcers in Patients with Therapy-Resistant Wounds
GermanyThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
